Episode 138 | What The Abortion Industry Doesn’t Want You To Know About Repeat Abortions

Episode 138 | What The Abortion Industry Doesn’t Want You To Know About Repeat Abortions

Are repeat abortions only a tiny fraction of the abortion rate? Are teens having multiple abortions? Does having multiple abortions impact a woman’s health? Is more contraception the answer? We answer all this and more in an episode revealing the truth about repeat abortion – and its effects – that the abortion industry can’t afford for people to hear.

Episode 137 | Censorship In The War Of Ideas

Episode 137 | Censorship In The War Of Ideas

This week we are talking about what one journalist describes as the ongoing “censorship-industrial complex.” We discuss the fine PayPal hoped would go unnoticed, Google’s new pro-choice AI, Google and Yelps attempts to curb Pregnancy Resource Centers and pro-life groups from popping up in search results & ads – as well as what this means for women. Plus we discuss journalists testifying before congress about how some government agencies and their contractors have been pressuring social media companies to censor Americans. This is an episode everyone needs to hear!

Episode 136 | States Respond To Chemical Abortions

Episode 136 | States Respond To Chemical Abortions

In the patchwork quilt that is America post- Roe, chemical abortion is becoming the new battleground in the states. We discuss the new laws emerging on either side of the abortion pill issue, the looming decision of a Texas federal judge on whether to suspend the FDA’s approval of mifepristone, and how a group of hobby pilots are fly abortion patients out of states with bans. Plus, we discuss the new study showing hormonal birth control elevates the risk of breast cancer.

Episode 134 | Strange Allies In The Pro-Abortion Movement

Episode 134 | Strange Allies In The Pro-Abortion Movement

An often overlooked aspect of the abortion lobby is that it is a living example of the old saying, “Politics makes strange bedfellows.” This week, we look at some of the strange allies of the pro-abortion movement and how their personal agendas are joined at the hip with legalized abortion. We reveal that some people do actually LOVE abortion, and we discuss how a growing number on the pro-choice side are trying to frame abortion as an act of love.

Episode 133 | Is The Pro-Choice Side Openly Admitting Abortion’s Connection To Satanism?

Episode 133 | Is The Pro-Choice Side Openly Admitting Abortion’s Connection To Satanism?

At Life Dynamics, we have discussed the connection between abortion and Satanism over the years. But with a newly mounted satanic looking statue atop a New York court building dedicated to Ginsburg and abortion, and the Satanic Temple to open a ritualistic telemed abortion clinic, could the pro-abortion side be finally admitting it’s connection to Satanism?

Episode 132 | Responding To Pro-Choice Comments / Arguments – Volume 2

Episode 132 | Responding To Pro-Choice Comments / Arguments – Volume 2

Listeners who enjoyed episode 66, where we respond to pro-choice comments on Instagram, will be in for a treat this week. On this episode of the Pro-Life America podcast, we respond to pro-choice arguments and comments made by pro-choicers online. From tweets, to videos, to Reddit threads, to YouTube comments, we searched for some of the best examples of pro-choice logic. Enjoy!

Episode 131 | Latest Abortion Related News Reveals Who Is Actually Extreme

Episode 131 | Latest Abortion Related News Reveals Who Is Actually Extreme

This week on the Pro-Life America podcast, we discuss how Democrats are rallying against protecting babies born alive during abortions and calling it “extreme.” Meanwhile, new research by the Abortion Survivors Network reveals that 1,900+ children are “potentially” surviving abortions each year in the U.S. – contradicting claims from the left that abortion survivors are rare. And as some states are setting up to become abortion tourist hotspots, some pharmacies are expressing hesitation over offering the abortion pill in response to the FDA’s decision last week.